Medicinova (MNOV) Treasury Shares (2010 - 2013)

Medicinova (MNOV) posted quarterly Treasury Shares of $1.1 million for Q3 2013, little changed quarter-over-quarter from $1.1 million in Q2 2013.

Medicinova (MNOV) Treasury Shares (2010 - 2013) Analysis & Trends

Medicinova (MNOV) has reported Treasury Shares for 4 consecutive years, with $1.1 million the latest figure, recorded in Q3 2013.

In Q3 2013, Treasury Shares changed N/A year-over-year to $1.1 million; the TTM figure through Sep 2013 stood at $1.1 million (changed N/A YoY), while the FY2012 annual figure was $44705.0, down 96.24% from the prior year.
Treasury Shares held at $1.1 million in Q3 2013 per MNOV's latest filing, from $1.1 million in the prior quarter.
Across five years, Treasury Shares topped out at $43735.0 in Q4 2010 and bottomed at $4186.0 in Q3 2012.
Historically, Treasury Shares has averaged $27664.5 across 3 years, with a median of $31825.0 in 2011.
Annual changes were most pronounced in 2011 — Treasury Shares retreated 0.69% — and 2012, when it slumped 96.24%.
Medicinova's Treasury Shares stood at $1.2 million in 2010, then decreased by 0.69% to $1.2 million in 2011, then plunged by 96.24% to $44705.0 in 2012, then surged by 2415.13% to $1.1 million in 2013.
Business Quant data shows MNOV's Treasury Shares at $1.1 million in Q3 2013, $1.1 million in Q2 2013, and $1.1 million in Q1 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Medicinova	68.42 Mn	68.42 Mn	317,759.00	-

Download Data